Size-selective downstream processing of virus particles and non-enveloped virus-like particles.

downstream processing purification size-selective vaccines virus particles virus-like particles

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2023
Historique:
received: 22 03 2023
accepted: 08 05 2023
medline: 12 6 2023
pubmed: 12 6 2023
entrez: 12 6 2023
Statut: epublish

Résumé

Non-enveloped virus-like particles (VLPs) are versatile protein nanoparticles with great potential for biopharmaceutical applications. However, conventional protein downstream processing (DSP) and platform processes are often not easily applicable due to the large size of VLPs and virus particles (VPs) in general. The application of size-selective separation techniques offers to exploit the size difference between VPs and common host-cell impurities. Moreover, size-selective separation techniques offer the potential for wide applicability across different VPs. In this work, basic principles and applications of size-selective separation techniques are reviewed to highlight their potential in DSP of VPs. Finally, specific DSP steps for non-enveloped VLPs and their subunits are reviewed as well as the potential applications and benefits of size-selective separation techniques are shown.

Identifiants

pubmed: 37304136
doi: 10.3389/fbioe.2023.1192050
pii: 1192050
pmc: PMC10248422
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1192050

Informations de copyright

Copyright © 2023 Hillebrandt and Hubbuch.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Hum Gene Ther. 2021 Sep;32(17-18):959-974
pubmed: 33554722
J Pharm Sci. 2006 Oct;95(10):2195-206
pubmed: 16871523
Methods. 2006 Sep;40(1):60-5
pubmed: 16997714
J Chromatogr A. 2017 Feb 3;1483:110-119
pubmed: 28069171
J Virol Methods. 2010 Apr;165(1):83-9
pubmed: 20116403
Biochemistry. 1995 Apr 18;34(15):4919-32
pubmed: 7711014
Expert Rev Vaccines. 2011 Oct;10(10):1451-75
pubmed: 21988309
Front Bioeng Biotechnol. 2020 May 25;8:489
pubmed: 32671023
J Biol Chem. 2003 May 16;278(20):18249-55
pubmed: 12639968
Gene Ther. 2000 Jun;7(11):910-3
pubmed: 10849549
Expert Rev Vaccines. 2007 Jun;6(3):381-90
pubmed: 17542753
Microorganisms. 2021 Jan 30;9(2):
pubmed: 33573151
Vaccine. 2012 Dec 17;31(1):58-83
pubmed: 23142589
Curr Gene Ther. 2018;18(6):366-374
pubmed: 30411681
J Invertebr Pathol. 2011 Jul;107 Suppl:S42-8
pubmed: 21784230
Sci Rep. 2020 Oct 1;10(1):16261
pubmed: 33004836
Mol Ther Methods Clin Dev. 2016 Feb 10;3:15058
pubmed: 26913289
Front Bioeng Biotechnol. 2022 Dec 14;10:1051129
pubmed: 36588941
Biotechnol Bioeng. 2021 Oct;118(10):3926-3940
pubmed: 34170511
Biotechnol Bioeng. 2014 Mar;111(3):425-40
pubmed: 24347238
J Chem Technol Biotechnol. 2018 Jul;93(7):1988-1996
pubmed: 30008506
Biotechnol Bioeng. 2021 Oct;118(10):3996-4013
pubmed: 34219217
Mol Ther Methods Clin Dev. 2020 Mar 30;17:717-730
pubmed: 32346549
J Biotechnol. 2020 Nov 10;323:221-230
pubmed: 32860824
J Biotechnol. 2007 Jan 10;127(3):452-61
pubmed: 16959354
Sci Rep. 2017 Mar 03;7:43160
pubmed: 28256592
J Virol. 2010 Jul;84(14):7174-84
pubmed: 20427522
Protein Expr Purif. 2010 Mar;70(1):68-74
pubmed: 19686852
Adv Exp Med Biol. 2009;655:145-58
pubmed: 20047040
Expert Opin Biol Ther. 2020 May;20(5):451-465
pubmed: 31773998
J Gen Virol. 2006 Sep;87(Pt 9):2749-2754
pubmed: 16894216
J Virol Methods. 2012 Apr;181(1):6-11
pubmed: 22265819
Protein Expr Purif. 2021 Feb;178:105747
pubmed: 32898688
Biotechnol Bioeng. 2005 Oct 20;92(2):199-208
pubmed: 16041807
Mol Ther Methods Clin Dev. 2018 Nov 01;11:180-190
pubmed: 30533449
J Virol Methods. 2014 Oct;207:45-53
pubmed: 24992667
Virol J. 2012 Feb 22;9:52
pubmed: 22356831
PLoS Comput Biol. 2012;8(2):e1002367
pubmed: 22359487
J Gene Med. 2007 Apr;9(4):233-43
pubmed: 17428003
J Virol Methods. 2008 Aug;151(2):172-180
pubmed: 18584885
Sci Rep. 2015 Jun 26;5:11639
pubmed: 26113394
Curr Protoc Protein Sci. 2001 May;Appendix 3:Appendix 3F
pubmed: 18429073
Biotechnol Adv. 2011 Nov-Dec;29(6):869-78
pubmed: 21784144
J Biol Chem. 2015 Jun 26;290(26):16238-45
pubmed: 25953902
Biochemistry. 1996 Jun 11;35(23):7412-21
pubmed: 8652518
J Nanobiotechnology. 2018 Apr 13;16(1):39
pubmed: 29653575
Biotechnol J. 2015 May;10(5):715-27
pubmed: 25880158
Hum Gene Ther. 2011 Mar;22(3):343-56
pubmed: 21043787
J Chromatogr A. 2019 Mar 15;1588:77-84
pubmed: 30616980
Front Bioeng Biotechnol. 2022 Jul 01;10:929243
pubmed: 35845397
Front Bioeng Biotechnol. 2020 Jul 31;8:881
pubmed: 32850736
Vaccine. 2019 Nov 8;37(47):7061-7069
pubmed: 31201056
Expert Rev Vaccines. 2010 Oct;9(10):1149-76
pubmed: 20923267
Biotechnol J. 2019 Aug;14(8):e1800570
pubmed: 31106962
Biotechnol Bioeng. 2019 Jun;116(6):1366-1379
pubmed: 30684365
Vaccine. 2011 Sep 22;29(41):7154-62
pubmed: 21651936
Gene Ther. 2005 Oct;12 Suppl 1:S103-10
pubmed: 16231042
N Biotechnol. 2017 Oct 25;39(Pt B):174-180
pubmed: 28778817
Protein Expr Purif. 1999 Dec;17(3):477-84
pubmed: 10600468
Life (Basel). 2021 Apr 10;11(4):
pubmed: 33920215
J Chromatogr A. 2012 Dec 28;1270:162-70
pubmed: 23182281
Biotechnol Bioeng. 2009 Aug 15;103(6):1144-54
pubmed: 19449393
J Biotechnol. 2016 Feb 20;220:12-20
pubmed: 26712479
J Nanobiotechnology. 2021 Feb 25;19(1):59
pubmed: 33632278
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jan;12(1):e1579
pubmed: 31456339
Nanomedicine. 2012 Oct;8(7):1182-9
pubmed: 22306156
J Biol Chem. 2006 Jul 14;281(28):19478-88
pubmed: 16675449
Vaccines (Basel). 2018 Jul 02;6(3):
pubmed: 30004398
PLoS One. 2014 Apr 08;9(4):e94401
pubmed: 24713807
Curr Opin Biotechnol. 2004 Dec;15(6):513-7
pubmed: 15560977
J Immunol. 2012 Apr 15;188(8):3724-33
pubmed: 22427639
Biotechnol Bioeng. 2022 Jun;119(6):1522-1538
pubmed: 35170757
J Biotechnol. 2007 Sep 15;131(3):309-17
pubmed: 17765993
J Chromatogr A. 2021 Feb 22;1639:461924
pubmed: 33545579
Biotechnol Bioeng. 2015 May;112(5):843-57
pubmed: 25677990
Trends Biotechnol. 2005 Oct;23(10):523-9
pubmed: 16084615
Vaccine. 2022 Feb 23;40(9):1323-1333
pubmed: 35094870

Auteurs

Nils Hillebrandt (N)

Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

Jürgen Hubbuch (J)

Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

Classifications MeSH